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Preliminary Studies on the Fate of Inhaled Vinyl
Chloride Monomer (VCM) in Rats
by R. E. Hefner, Jr.,* P. G. Watanabe,* and P. J. Gehring*
Rats were exposed to vinyl chloride monomer gas (VCM) in a closed recirculating
system. The rate at which VCM was removed from the system via metabolism was
determined for rats exposed to initial concentrations of VCM ranging from 50 to 1167
ppm. Upon exposure to initial concentrations of 50 to 105 ppm, the rate of metabolism
was 8.04 + 3.40 X 10-8 min-1. Upon exposure to initial concentrations ranging from
220 to 1167 ppm, the rate constants were less; the mean value being 2.65 ± 1.35 X 10-8
min-'. Regardless of concentration, the disappearance followed apparent first order
kinetics.
Pretreatment of rats with pyrazole prior to exposure to initial concentrations of 65
and 1234 ppm VCM caused 71 and 87% reductions in the rate of metabolism. Ethanol
caused 96% and 83% reductions in the rate of VCM metabolism by rats exposed to 56
and 97 ppm VCM, respectively. Ethanol was less effective in blocking the rate of
metabolism by rats exposed to high concentrations of VCM; 46 and 36% in rats
exposed to 1025 and 1034 ppm VCM. In rats exposed to an initial concentration of 65
ppm VCM, SKF-525-A administration caused no inhibition of the rate of VCM metabolism;
however, a 19% inhibition was seen in rats exposed to 1038 ppm.
The nonprotein sulfhydryl content of the liver (glutathione and cysteine) of rats
exposed to VCM concentrations ranging from 50 to 15,000 ppm VCM is reduced without
a relationship to dose. With repeated daily exposure the degree of reduction is reduced.
Preliminary results indicate that the primary metabolites of VCM react with the non-
protein sulfhydryl. Final metabolic products excreted in the urine appear to be S-(2-
hydroxyethyl)cysteine and S-(2-carboxymethyl)cysteine and the respective N-acetyl
derivatives. Monochloroacetic acid was identified as another potential metabolite.
Considering the results in toto, it is hypothesized that VCM is readily and extensively
metabolized. Metabolism via the primary pathway, postulated to involve alcohol dehydro-
genase, is swamped by exposures to concentrations exceeding 220 ppm. In rats exposed
to concentrations at and exceeding this level, metabolism occurs via a secondary path-
way(s), postulated to be epoxidation and/or peroxidation. These results are considered
pertinent in assessing the potential hazard at low level exposures to VCM.
Introduction
Vinyl chloride monomer (VCM), extensively
used for the production of poly(vinyl chloride)
and other plastics, has been associated with the
development of angiosarcoma and portal cir-
rhosis of the liver as well as other untoward
effects in workers exposed to unknown but un-
doubtedly high concentrations of VCM. Angio-
sarcomas, zymbal gland carcinomas, and
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nephroblastomas developed in rats exposed to
concentrations of VCM ranging from 50 to
10,000 ppm, 4 hr per day, 5 days per week for
12 months, and subsequently maintained and
observed until death (1).
No information is available on the fate of
VCM in the mammalian organism. Such infor-
mation is essential for elucidating the toxico-
dynamics of VCM. This would provide a
rationale to assess the potential hazard of expo-
sure to low levels of VCM. Results of pre-
liminary studies on the fate of VCM in rats
exposed via inhalation are reported herein.
Prior to undertaking these studies it was postu-
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used for exposing rats to VCM.
lated that VCM might be metabolized via the
alcohol dehydrogenase pathway, and if so, this
pathway would very likely be saturable and
that conjugation of VCM or its metabolites
with glutathione and cysteine might be ex-
pected. Therefore, much of the work conducted
to date has been directed at evaluating these
possibilities.
Methods
Kinetic Studies of the Uptake (Metabolism)
of Inhaled Vinyl Chloride Monomer
Male Sprague-Dawley albino rats of Spartan
strain weighing from 165 to 200 g were exposed
to initial concentrations of VCM gas ranging
from 51 to 1167 ppm (0.13 to 2.99 mg/l.).
Exposures ranged from 52.5 to 356.3 min.
Figure 1 depicts the closed, recirculating 4.7-1.
inhalation apparatus in which a group of four
rats were concurrently exposed. To minimize
contamination of fur and skin, only the nares
of the rats protruded through a rubber mem-
brane into the chamber. Expired carbon dioxide
was continuously removed from the chamber
by absorption on an Ascarite column in the
recirculating system. As carbon dioxide was
removed from the system, the pressure drop
was detected by a mercury manometer fitted
with a photoelectric cell. This activated a sole-
noid valve and dual syringe pump to inject
makeup oxygen into the system.
The chamber atmosphere was continuously
analyzed for VCM (10.9 M) by an in-line
Miran-I infrared analyzer (Wilks). Using
known concentrations of VCM prepared in
100-1. Saran bags, the absorbance versus con-
centration adhered to the Beer-Lambert Law.
Duringthe exposures, routine checks for carbon
dioxide in the chamber atmosphere were made
at 4.26 A. Oxygen consumption for each experi-
ment was determined directly by measuring
the oxygen metered into the system using a
dry test meter (American Meter Co.).
Prior to each exposure, the desired initial
concentration of VCM (Matheson Gas Prod-
ucts, Joliet, Ill., 99.9%o pure) was generated
in the empty recirculating system and the
decline in concentration was followed for a
time equal to or exceeding that of the intended
experiment. The decline in concentration was
in accordance with first-order kinetics as
described by
dC/dt = -K1C (1)
where C (ppm) is the concentration of VCM
at time t (min) and K1 (min-1) is the rate
constant for the decline in VCM concentra-
tion from the empty recirculating system.
Regression analysis of the logarithm of the
concentration of VCM versus time yielded K1.
Initially values for K1 were determined before
and after inclusion of rats in the chamber.
These values were reproducible, therefore K1
was not redetermined after removal of the rats
in every subsequent experiment. Between ex-
periments, the system was disassembled,
cleaned, and reassembled with inclusion of a
new Ascarite column. The K1 for each re-
assembled system was unique, within certain
limits, which necessitated its redetermination
for each experiment.
After determining the rate of decline of VCM
concentration in the empty inhalation system,
four rats were placed in the chamber. The
chamber was then charged with the desired
concentration of VCM, and the rate of decline
of VCM concentration was determined as pre-
viously described. The rate of decline Ke fol-
lowed apparent first-order kinetics. After an
initial equilibration of the tissues of the rats,
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closed system was assumed to occur via metabo-
lism of VCM plus the background loss from
the system. Since oxygen consumptions were
within 10%o for all experiments described here-
in respiratory parameters were not signifi-
cantly changed. Therefore, respiratory param-
eters were not a factor influencing the rates of
metabolism. The rate of metabolism Kc would
therefore be given by eq. (2):
Kc-Ke Ki (2)
To assess the effects of potential inhibitors
of VCM metabolism, rats were pretreated by
intraperitoneal injection with 320 mg/kg pyr-
azole (1,2-diazole) 1 hr prior to exposure, 5 ml/
kg ethanol 1.5 hr prior to exposure, 75 mg/kg
SK&F-525-A (,8 - diethylaminoethyldiphenyl-
propyl acetate) 0.5, 0.6, 1.0, or 2.25 hr prior
to exposure, or 1000 mg/kg AT (3-amino-1,2,4-
triazole) 3 hr prior to exposure. Without clean-
ing or reassembling the inhalation system, both
untreated control rats and rats treated with the
chosen potential inhibitor were exposed to the
desired concentration of VCM. The inhibition
was calculated from eq. (3):
K, (control) - K, (treated) =
K, (control)
inhibition
(3)
Effects of VCM on Liver Sulfhydryl Levels
Groups of male Sprague-Dawley albino rats
of Spartan strain weighing from 193 to 250 g
at initiation of the experiment were exposed
to nominal concentrations of 15,000 ppm vinyl
chloride for 5 days, 5000 or 500 ppm 5 days
per week for 1, 3, or 7 weeks, and 50 ppm for
1 hr, 7 hr, or 5 days. The exposures were
carried out in a glass-walled 160-1. chamber
under dynamic conditions with the VCM being
metered into the chamber airstream. For re-
peated daily exposures, 7-hr exposures were
conducted on the first four of five consecutive
days each week. On the fifth day, if the rats
were to be sacrificed, the duration of exposure
was reduced to 5 to 6 hr; however, if the rats
were being continued on exposure, they received
a full 7-hr exposure.
The body weights and food consumption of
rats exposed to 500 and 5000 ppm VCM were
determined before each daily exposure and the
rats were observed periodically for signs of
toxicity. Between 1 and 2 PM, immediately
following the fifth exposure of the designated
week, the rats were killed by cervical disloca-
tion and the livers removed and assayed for
sulfhydryl content. Gross pathological examina-
tions were conducted.
The method used for the sulhydryl assay was
a modification of that described by Sedlak and
Lindsay (2). Exactly 500 mg of liver from
each rat was homogenized for 1 min in a
Dounce tissue homogenizer containing 8 ml of
0.02M disodium EDTA. For the total sulfhydryl
assay, a 0.5-ml aliquot of each homogenate
was mixed with 1.5 ml of 0.2M Tris HCI pH
9.2 buffer, 0.1 ml of 0.01M 5,5'-dithiobis(2-
nitrobenzoic acid) (DTNB), and 7.9 ml of
methanol. A reagent blank without liver homo-
genate, and a sample blank, without DTNB,
were also prepared. The color generated via
the release of nitromercaptobenzoic acid anion
was allowed to develop for 15 min, and the
samples were centrifuged for 15 min at 4000g.
Absorbance of each sample was read against
the respective sample blank at 412 nm with a
Beckman DB spectrophotometer. Subsequently,
the molar concentration of total sulfhydryl in
the sample was calculated using an extinction
coefficient determined from standards of known
concentrations of glutathione or cysteine. A
plot of absorbance versus the concentration of
cysteine or glutathione coincided with that re-
ported by Sedlak and Lindsay (2).
The nonprotein sulfhydryl content of liver
was determined after precipitating out the pro-
tein by addition of 1 ml of a 50%o solution of
trichloroacetic acid in distilled water to a 5 ml
sample of liver homogenate. Each sample was
diluted with 4 ml of distilled water and after
15 min centrifuged at 4000g for 15 min. A 2-ml
aliquot of the supernatant was mixed with 4 ml
of 0.4M Tris HCl, pH 8.9 buffer. Immediately
before reading the absorbance against a reagent
blank, 0.1 ml of 0.01M DTNB was added.
Subtraction of the nonprotein sulfhydryl con-
tent from the total sulfhydryl content yielded a
value for protein-bound sulfhydryl.
Urine samples collected from rats exposed
to 5000 ppm vinyl chloride for 4, 5, and 7
weeks were analyzed for the presence of
S-(2-chloroethyl)cysteine, S-(2-hydroxyethyl)-
cysteine, and S-(carboxymethyl)cysteine (5
and 7 week samples only). Urine was collected
for analysis by applying pressure to the pos-
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hour of the fifth daily exposure on the desig-
nated week. Urine collected on the same day
was pooled. For the three aforementioned com-
pounds, 2 to 15 1Al of urine were spotted directly
on a 5 by 20 cm Baker-Flex silica gel plate.
Also spotted were samples or urine collected
from control rats and standard aqueous solu-
tions as well as control urine to which approxi-
mately 1 ug/Lg of each of the compounds had
been added. The chromatograms were developed
for 5 hr in a sealed glass tank containing
n-butanol, acetic acid, and water (80:10:10 or
60:20:20). After being air dried, the plates
were sprayed with Ninspray ninhydrin reagent
and heated for 2 min at 80°C. The color of the
spots and their R, values were used to identify
the compounds.
A urine sample collected from rats exposed
to 5000 ppm vinyl chloride for 9 weeks was
analyzed for the presence of chloroacetic acid.
The 10 ml urine sample was acidified with 0.1
ml of 50%7 (v/v)H2SO4. Subsequently, the urine
sample was extracted three times with 2 ml of
diethyl ether. The diethyl ether extract was
evaporated to 0.1 ml, and 2-15 ul of the con-
centrated extract and an aqueous standard con-
taining 5% (w/v) chloroacetic acid were
spotted on an Eastman fluorescent silica gel
plate. The chromatograms were developed in
a sealed glass tank for 5 hr using the afore-
mentioned solvent systems. After air drying
the plates, they were examined under ultra-
violet light to determine the location of spots.
Subsequently, the plates were treated with nin-
hydrin as described previously.
Urine collected from four rats for 12 hr
after exposure to 7855 ppm 14C-VCM (specific
activity 0.2 mCi/mmole) for 62 min was pooled
and analyzed for metabolites. A 3.0-ml portion
of urine was applied to 22.2 by 1.5 cm Dowex
50 (49 crosslinked, sodium form, 200-400
mesh) column and eluted with a 0.O1M Tris
HCI, pH 7.0 to 3.0 gradient. A 10-12 ul por-
tion of each fraction containing 14C activity
was spotted on a 5 by 20 cm silica plate. As
standards, 2 ug of S-(2-hydroxyethyl)cysteine
and S-(2-carboxymethyl)cysteine were spotted
on the plates. The chromatograms were devel-
oped in a sealed glass tank containing n-pro-
panol and ammonia solution (289%), 70:30.
After air drying, the plates were analyzed for
14C activity by using a Panax thin-layer chro-
matogram radioscanner and liquid scintillation
counting techniques. A single minor fraction
of 14C activity was analyzed as previously de-
scribed, however 2 jug of urea was spotted on
the plates as a standard. Chromatograms were
developed in sealed glass tanks containing
n-propanol, 28%So ammonia solution, 70:30;
ethanol, 28%o ammonia solution, 70:30; n-pro-
panol, acetic acid, 90:10; or n-butanol, acetic
acid, water, 60:20:20.
Results
Kinetic Studies on the Metabolism of
Inhaled VCM
Typical declines in the concentration of VCM
in the inhalation apparatus containing four
rats and initial concentrations of approximately
50 or 1000 ppm are shown in Figure 2. Also
shown are the corresponding declines in the
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FIGURE 2. Typical declines in VCM concentration with
time at approximately 50 and 1000 ppm VCM ex-
posure concentrations. Also shown are the respective
declines in VCM concentration for the unoccupied
inhalation apparatus.
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FIGURE 3. Declines in VCM concentration with time
at 65 and 1234 ppm VCM exposure concentrations
for both pyrazole pretreated and untreated control
rats. Also shown are the respective declines in VCM
concentration for the unoccupied inhalation appa-
ratus.
concentration of VCM from the unoccupied
chamber. As indicated above, the rate of these
declines, Ke and K1, respectively, were deter-
mined by regression analysis. The rate of
metabolism, Ke, was assumed equal to Ke - K1.
For seven separate exposures to concentrations
of VCM ranging from 50 to 105 ppm, the mean
and standard deviation for the apparent first-
order rate constant Kc were -8.04 X 10-3 +
3.40 X 10-3 min-'. This corresponds to a half-
life t1/2 of 86 min.
For five separate exposures to concentrations
of VCM ranging from 220 to 1167 ppm, Kc
was -2.65 X 10- 1.35 X 10- min-'. This
corresponds to a t11, of 261 min. As indicated
by the standard deviations, there was variation
of Kc within the indicated range of concentra-
FIGURE 4. Declines in VCM concentration with time
at 56 and 1034 ppm VCM exposure concentrations
for both ethanol pretreated and untreated control
rats. Also shown are the respective declines in VCM
concentration for the unoccupied inhalation appa-
ratus.
tion, however, there was no consistent trend
for the values of Kc within this range.
Administration of 320 mg/kg pyrazole, an
inhibitor of alcohol dehydrogenase, xanthine
oxidase, and other enzymes (3) 1 hr before
exposure to 65 and 1234 ppm VCM resulted in
71.2 and 86.9% inhibition of metabolism of
VCM, respectively (Fig. 3).
Because of the lack of specificity of pyrazole
as an enzyme inhibitor, 5 ml/kg 95% ethanol
was administered to rats in an attempt to spe-
cifically inhibit alcohol dehydrogenase activity.
In rats exposed to initial concentrations of 56
and 97 ppm VCM, ethanol pretreatment caused
96.0 and 82.9% inhibition of VCM metabolism,
respectively. When rats were pretreated with
ethanol and exposed to initial concentrations
of 1025 and 1034 ppm VCM, inhibition of
metabolism was 46.5 and 35.7%c, respectively.
Figure 4 illustrates the inhibition for separate
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FIGURE 6. Declines in VCM concentration with time
at 940.6 ppm VCM exposure concentrations for both
AT pretreated and untreated control rats. Also shown
is the respective decline in VCM concentration for
the unoccupied inhalation apparatus.
Pretreatment of rats with 1000 mg/kg AT,
an inhibitor of liver catalase activity (5), re-
sulted in a 16.4%o inhibition of VCM metabo-
lism in rats exposed to an initial concentration
of 941 ppm VCM (Fig. 6).
Effect of Inhaled VCM on Liver
Sulfhydryl Levels
30 45
Duration Of Exposure, Min.
FIGURE 5. Declines in VCM concentration with time
at 65 and 1038 ppm VCM exposure concentrations
for both SK&F-525-A pretreated and untreated con-
trol rats. Also shown are the respective deadlines in
VCM concentration for the unoccupied inhalation
apparatus.
experiments conducted at extremes of initial
VCM concentrations.
Pretreatment of rats 0.5 hr previous to expo-
sure to VCM with 75 mg/kg SK&F-525-A, an
inhibitor of some types of microsomal oxidases
(4), resulted in no inhibition of metabolism of
VCM in rats exposed to initial concentrations
of 61 or 65 ppm and an 18.8% inhibition in
those exposed to 1038 ppm (Fig. 5). Additional
exposures of rats pretreated 0.6, 1, or 2.25 hr
with 75 mg/kg SK&F-525-A to approximately
1000 ppm VCM resulted in 8.9, 6.5, and 4.5%
inhibition of VCM metabolism, respectively.
No antemortem or postmortem signs of toxic-
ity were noted in rats exposed to any concen-
tration of VCM used in these experiments.
Analysis of food consumption data for rats
exposed to nominal concentrations of 500 or
5000 ppm VCM, and unexposed controls re-
vealed no statistically significant differences.
In addition, no significant difference was found
in the water consumption of rats exposed to
5000 ppm and controls. Throughout the dura-
tions of observation, the mean body weights
of rats exposed to the various concentrations
of VCM were essentially the same as those of
the respective controls. No gross pathological
lesions related to exposure of VCM, were found
in any of the rats.
Table 1 shows the nonprotein sulfhydryl con-
tent of the liver of rats exposed to 50, 500,
5000, or 15,000 ppm VCM for the indicated
durations. Values for concurrent controls are
also given. In Figure 7, these data are sum-
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FIGURE 7. Depression of nonprotein sulfhydryl in the
liver of rats as a function of VCM exposure con-
centration and duration of exposure.
marized and expressed as the per cent depres-
sion of the nonprotein sulfhydryl content of
the liver as a function of exposure concentra-
tion and duration of exposure. Significant re-
ductions in the levels of nonprotein sulfhydryl
occurred in rats exposed to 50 ppm VCM for
7 hr, 500 and 5000 ppm for 1 and 3 weeks,
Table 1. Nonprotein sulfhydryl content in livers of rats
exposed to VCM and in concurrent controls.
Sulfhydryl contentX10s, mole/mg
liver after various exposure times
VCM conen,
ppm 7 hr/day, 7 hr/day, 7 hr/day,
for 5 days 5 days/wk, 5 days/wk,
for 3 weeks for 7 weeks
15,000 0.29 -4 0.08-
Control 0.42±+0.07
5,000 0.33±0.02& 0.41-0.03a 0.59±0.08
Control 0.464±0.03 0.72 -0.03 0.70±i0 0.02
500 0.35±0.09& 0.45±0.061 0.58±0.06
Control 0.58±40.06 0.61±0.08 0.64±0.08
50b 0.34±0.01
Control 0.43 ±0.09
a Significantly different by using Student's t test, p <0.05.
b A single 1-hr exposure to 50 ppm VCM resulted in
0.64±0.05 and 0.65±0.06 for the concurrent controls. A
single 7-hr exposure to 50 ppm VCM resulted in 0.17±0.07
and 0.44±0.08 for the concurrent controls.
and 15,000 ppm for 1 week. There is no defini-
tive association between exposure concentration
and the degree of depression. The degree of
depression decreases with continued exposure
which suggests compensatory mechanisms(s)
are responding to relieve this biochemical effect
induced by VCM.
The protein-bound sulfhydryl content of the
liver of rats exposed to 50, 500, 5000, or 15,000
ppm VCM for the indicated durations were
not significantly different from those of the
concurrent controls. This was not unexpected
because the sulfhydryl groups of protein have
been shown not to be readily akylated unless
denaturation of the protein renders them avail-
able for alkylation (6).
Effect of Ethanol Administration on
VCM-Induced Depression of Nonprotein
Sulfhydryl in Liver
In this experiment, four rats pretreated with
5 ml/kg ethanol and four untreated control
rats were exposed to 1070 ppm VCM. Follow-
ing 105 min of exposure, the concentration of
nonprotein sulfhydryl in the liver was deter-
mined. For those pretreated with ethanol, the
depression of nonprotein sulfhydryl was
77.0 ± 12.8%, while for controls it was
95.0 ± 3.4%. These levels of depression were
significantly different as determined by Stu-
dent's t test, p <0.05. Johnson (7) has reported
that ethanol alone does not affect the non-
protein sulfhydryl content of the liver.
Metabolites of VCM
Preliminary results which must be viewed
with considerable reservation have been ob-
tained from studies in which rats were exposed
to 5000 ppm unlabeled VCM for 4, 5, or 7 weeks.
Thin-layer chromatograms of urine collected
from rats after each of these exposure dura-
tions were comparable. S-(2-Hydroxyethyl)
cysteine (Rf = 0.26-0.28 in 80:10:10 nmbutanol,
acetic acid, water) appeared to present. S-(2-
Hydroxyethyl)cysteine was not present in a
thin-layer chromatogram of urine collected
from control rats. S-(2-Chloroethyl)cysteine
and S-(2-carboxymethyl)cysteine were not de-
tected; however, it is conceivable that the latter
compound was not adequately resolved from the
urine background.
June 1975
VINYL CHLORIDE CONCENTRATION
3
3
91In another experiment, chromatograms of
urine from rats exposed to 5000 ppm VCM
for. 9 weeks revealed the presence of mono-
chloroacetic acid (Rf = 0.74 in n-butanol,
acetic acid, water, 80:10:10). The spots for
monochloroacetic acid were visualized under
ultraviolet light on the fluorescent plates and
did not develop with ninhydrip reagent.
Studies of the metabolism of VCM were
terminated until *methods were developed to
synthesize 14C-VCM. 14C-VCM in a liquid state
polymerized even when an inhibitor was present
and a temperature of -70°C was maintained.
Recently, a method has been developed to syn-
thesize 14C-VCM in a gaseous state from 1,2-
dichloroethane (8). In the gaseous state, 144C0
VCM is stable.
Three 180-g male rats were exposed to 14C0
VCM in the closed recirculating system for 65
min. The initial concentration of 14C-VCM with
a specific activity of 1.155 mCi/mmole was 49
ppm. Assuming equivalent uptake of VCM by
the three rats, each rat received 0.49 mg/kg
VCM. Immediately following exposure, the rats
were removed from the chamber and placed
in Roth type metabolism cages which allow
separate collection of urine, feces, expired
carbon dioxide, and any expired VCM.
Within 15 hr after exposure, a mean of
58.0%7o of the 14C activity had been excreted
in the urine, 2.7%o in the feces, and 9.8%o
as expired carbon dioxide. By 75 hr after ex-
posure, 67.1%'o had been excreted in the urine,
3.8% in the feces, and 14.0% as expired carbon
dioxide. Only a trace, 0.02% of the dose, was
expired as VCM and trapped on activated
carbon. After 75 hr, 1.6%b of the dose remained
in the liver, 3.6%o in the skin, 0.2%o in the kid-
neys and 7.6%o in the remaining carcass. The
mean recovery of the assumed dose from the
three rats was 97.9%o.
Chromatograms of the major fraction
(97.9%o) of '14C activity obtained from ion-
exchange separation of urine of rats exposed
to 7855 ppm 14C-VCM for 62 min revealed the
presence of three major VCM urinary metabo-
lites. R, values for these urinary metabolites
do not exactly coincide with those for the S-
(2-hydroxyethyl)cysteine or S-(2-carboxy-
methyl)cysteine standards; thus, if these com-
pounds are present, they are likely present as
mercapturic acids (N-acetylated) or other de-
rivatives (sulfoxide, sulfone). Chromatograms
of a single minor fraction (1.2%b) of 14C ac-
tivity indicated the presence of 14C urea as a
minor VCM urinary metabolite.
In summary, metabolism studies have demon-
strated tentatively the following.
VCM is quite readily metabolized to polar
metabolites which are excreted predominantly
in the urine of rats exposed via inhalation to
an initial concentration of 50 ppm. Smaller
amounts of 14C activity are excreted in the
expired air as carbon dioxide and in the feces.
Very little is excreted in expired air as un-
changed VCM.
A significant but small amount of 14C activity
is retained in tissue, particularly liver, as long
as 75 hr after exposure.
Metabolites excreted in the urine appear to
be conjugated with glutathione and/or cysteine
through covalent linkage to the sulfhydryl
group. This is consistent with the reduction
of the nonprotein free sulfhydryl levels in the
livers of exposed rats. Preliminary in vitro
experiments (unpublished data) have shown
that direct conjugation of vinyl chloride with
cysteine or glutathione in aqueous solutions
occurs to a small degree but very slowly.
Monochloroacetic acid also appears to be a
metabolite of VCM, when rats were exposed
to 5000 ppm for an extended time.
Discussion
Because of the preliminary nature of some
of the studies reported herein, the results and
subsequent discussion must not be considered
conclusive. Justification for premature publica-
tion of some of the data contained herein is
the magnitude of the impact of recently re-
vealed toxicological effects of VCM and the
urgent need for communication of even pre-
liminary results.
The studies reported herein have demon-
strated reliably in some instances and tenta-
tively in others the following.
Rats exposed to concentrations of VCM below
100 ppm metabolize the compound quite readily
and in accordance with first-order rate kinetics,
ti = 86 min.
When exposed to a concentration of VCM
exceeding 220 ppm, its rate of metabolism was
reduced, t,2= 261 min. This indicates that the
predominant pathway for metabolism of VCM
by rats exposed to 100 ppm or less is saturable.
Environmental Health Perspectives 92Residual metabolism at concentrations exceed-
ing 220 ppm may be via this pathway in con-
junction with additional pathway(s).
Pyrazole inhibits the metabolism of VCM
suggesting that metabolism of VCM is via
alcohol dehydrogenase.
Stronger evidence for the metabolism of VCM
by alcohol dehydrogenase was its inhibition by
the administration of ethanol. This inhibition
was less pronounced in rats exposed to 1000
ppm than in rats exposed to 100 ppm or less,
suggesting that metabolism via pathways other
than that of alcohol dehydrogenase occurs in
rats exposed to 1000 ppm VCM.
,8 - Diethylaminoethyldiphenylpropyl acetate
(SK&F-525-A) does not affect the metabolism
of VCM by rats exposed to approximately 65
ppm VCM but there is an indication that it
slightly depresses metabolism by rats exposed
to approximately 1000 ppm VCM. This suggests
that in rats exposed to concentrations of VCM
which exceed the capacity of the alcohol dehy-
drogenase pathway metabolism may occur via
oxidases in the microsomes.
3-Amino-1,2,4-triazole (AT) slightly de-
presses the metabolism of VCM by rats ex-
posed to 1021 ppm of VCM. This suggests that
in rats exposed to concentrations of VCM which
exceed the capacity of the alcohol dehydro-
genase pathway, metabolism may occur via
catalase.
Monochloracetic acid was found in urine of
rats exposed to 5000 ppm VCM daily for 9
weeks.
Exposure to VCM reduces the nonprotein
sulfhydryl concentration of liver. This reduc-
tion is not definitively associated with the ex-
posure concentration of VCM in a range of 50
to 15,000 ppm. There is a tendency for the re-
duction to become less pronouncedwith repeated
daily exposures. These results are consistent
with a saturable mechanism for the metabolism
of VCM followed by conjugation of the metabo-
lites of VCM with glutathione and/or cysteine.
The administration of ethanol significantly
reduces the depression of the concentration of
nonprotein sulfhydryl in the livers of rats
caused by exposure to 1000 ppm VCM for 105
min.
In rats exposed to 49 or 847 ppm, VCM is
metabolized to polar products which are ex-
creted predominantly in the urine. These prod-
ucts appear to be derived following initial
metabolism of VCM and subsequent conjugation
of the products with glutathione and/or cy-
steine through covalent binding with the sulf-
hydryl. A small but significant fraction of
VCM is metabolized to CO2 and expired. An
even smaller but significant amount of 14C
activity appears to be retained in the liver
primarily, but also in other tissues as long as
75 hr after exposure.
Considering the results in toto, we hypothe-
size that in rats exposed to concentrations of
VCM below 100 ppm, VCM is predominantly
metabolized via sequential oxidation to 2-
chloroethanol, chloroacetaldehyde, and mono-
chloroacetic acid by the alcohol dehydrogenase
pathway [eq. (4)].
CIHC = CH2 -. CICH-CH,20Halcohol
dehydrogenase
CIH2C-CHO -* CICH,-COOH (4)
Only small amounts, if any, of monochloroacetic
acid are formed at low doses because chloro-
acetaldehyde reacts rapidly with the sulfhydryl
of glutathione and cysteine (9). This conju-
gation accounts for the lack of dose related
reduction in the nonprotein sulfhydryl content
of the liver of rats exposed to 50 through 15,000
ppm VCM.
Alternate pathways of VCM metabolism
which may be involved at high doses are at
this time purely speculative. However, at 220
ppm, metobolism by the more rapid alcohol
dehydrogenase pathway appears to be satu-
rated, and metabolism via oxidation of the ac-
cumulating 2-chloroethanol may occur as in
eq. (5).
C1CH3-CH2OH '202'C1HC,-CH200H-*C1CH2-CHO
catalase
(5)
Carter et al. (3) have demonstrated that
microsomal oxidation of ethanol in vitro pro-
ceeds via the formation of hydrogen peroxide
and catalase which subsequently forms a
peroxide of ethanol. Acetaldehyde is the end
product of this oxidation. It is conceivable that
a similar oxidation of 2-chloroethanol occurs.
In addition to this series of reactions, a
direct epoxidation of VCM may occur [eq. (6)].
0
ClCH = CH2 oxidase H2C-\H
C'
CICH2-CHO )-.C1CH,-COOH (6)
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oxide spontaneously rearranges to chloroace-
taldehyde. Such mechanisms would explain why
SK&F-525-A causes a slight inhibition of
metabolism in rats exposed to approximately
1000 but not 65 ppm VCM. Also it may explain
why monochloroacetic acid may be excreted by
rats exposed to 5000 ppm but not 50 ppm VCM.
In the former case, chloroacetaldehyde is pro-
duced by each of the hypothesized pathways
which may result in a greater amount being
oxidized to monochloroacetic acid than being
conjugated with glutathione and/or cysteine.
Inferences from the results of these studies
about the toxicodynamics of VCM are pre-
liminary, but worth mentioning. First, the
saturation of a primary metabolic pathway for
VCM degradation and redirection through other
pathways provides some hope that a threshold
concentration for the untoward effects of VCM
may exist. Metabolites of VCM formed only
via the alternate pathways may constitute the
ultimate toxin and carcinogen.
It has been reported (6,11-14) that the ad-
ministration of cysteine or glutathione provides
protection against the untoward effects of vari-
ous aliphatic and aromatic mustards, triethy-
lenemelamine, x-rays, and ionizing radiation.
Conceivably, cysteine and glutathione may pro-
vide a natural defense against tumor producing
free radicals generated within the body, as
well as synthetic or naturally occurring alky-
lating agents which are absorbed into the body.
Therefore, reduction of the nonprotein sulfhy-
dryl content of the liver in animals exposed to
VCM may constitute predisposition to toxicity
and carcinogenicity mediated via other ma-
terials.
Finally, the speculated formation of chloro-
ethylene oxide seems particularly pertinent in-
sofar as postulation of the mechanism of car-
cinogenesis. This compound is undoubtedly a
very active difunctional alkylating agent. It
is most interesting that inorganic arsenicals
have been reported to cause untoward hepatic
effects, portal cirrhosis and angiosarcoma, like
those reported for VCM (H. Popper, National
Institutes of Health, Bethesda, Md., personal
communication). The mechanism of toxicity for
arsenic has been shown to occur via its reaction
with 6,8-dithiooctanoic acid (a-lipoic acid) (15).
In this reaction arsenic forms a stable bridge
between the two sulfhydryl groups. If chloro-
ethylene oxide were formed, it would readily
react with a-lipoic acid, bridging the sulfhydryl
groups like arsenic [eq. (7)].
0
t\
H2C-CH + CH2-CH-CH-(CH2)4-COOH-
II
Cl SH SH
CH2-CH2-CH-(CH2)4-COOH (7)
S CH2-S
I
CH2
OH
Although this postulated mechanism is highly
speculative, the rarity of materials known to
produce untoward hepatic effects like those of
VCM must be given some weight.
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